Literature DB >> 7888151

Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis.

A Adem1, J Ekblom, P G Gillberg, S S Jossan, A Höög, B Winblad, S M Aquilonius, L H Wang, V Sara.   

Abstract

Neurotrophic factors are important for neuronal survival and maintenance in the adult nervous system. The regional distribution of insulin-like growth factor-1 (IGF-1) receptors in human spinal cords from controls and amyotrophic lateral sclerosis (ALS) patients was studied by immunohistochemistry and quantitative autoradiography. When comparing 125I-IGF-1 binding in the different spinal levels of normal spinal cord the same distribution pattern was found in which the binding was highest in the central canal > dorsal horn > ventral horn > white matter. In the ALS cases although a general upregulation of IGF-1 receptors was observed throughout the spinal cord, significant increases were observed in the cervical and sacral segments compared to controls. IGF-1 receptor immunoreactivity showed a similar pattern to that for 125I-IGF-1 binding, with immunoreactivity being found in the gray matter of the spinal cord and enhanced immunoreactivity occuring in ALS patients compared to controls. In agreement with the distribution of IGF-1 receptors, IGF-1 immunoreactivity was found within the gray matter of the spinal cord. The cartography of IGF-1 receptors in the normal spinal cord as well as the change of these receptors in diseased spinal cord may be of importance in future treatment strategies of ALS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888151     DOI: 10.1007/bf01277964

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  30 in total

1.  No re-expression of high-affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis.

Authors:  S M Aquilonius; H Askmark; T Ebendal; P G Gillberg
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

2.  Expression of the BRL-3A insulin-like growth factor binding protein (rBP-30) in the rat central nervous system.

Authors:  G Lamson; H Pham; Y Oh; I Ocrant; J Schwander; R G Rosenfeld
Journal:  Endocrinology       Date:  1989-08       Impact factor: 4.736

3.  Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization--relationship to IGF-I receptors.

Authors:  G A Werther; M Abate; A Hogg; H Cheesman; B Oldfield; D Hards; P Hudson; B Power; K Freed; A C Herington
Journal:  Mol Endocrinol       Date:  1990-05

4.  Patient resistance and prognosis in amyotrophic lateral sclerosis.

Authors:  D W Mulder; F M Howard
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

5.  Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation.

Authors:  J F Mill; M V Chao; D N Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Macroglobulinemia with peripheral neuropathy simulating motor neuron disease.

Authors:  L P Rowland; R Defendini; W Sherman; A Hirano; M R Olarte; N Latov; R E Lovelace; K Inoue; E F Osserman
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

7.  A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury.

Authors:  P Gluckman; N Klempt; J Guan; C Mallard; E Sirimanne; M Dragunow; M Klempt; K Singh; C Williams; K Nikolics
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

8.  Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.

Authors:  F A McMorris; T M Smith; S DeSalvo; R W Furlanetto
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

10.  Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.

Authors:  P Caroni; P Grandes
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

View more
  13 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  Effects of electro-acupuncture on IGF-I expression in spared dorsal root ganglia and associated spinal dorsal horn in cats subjected to adjacent dorsal root ganglionectomies.

Authors:  Ping Dai; Zhao-Jun Wang; Wei-wei Sun; Jiang-xia Pang; Chao You; Ting-Hua Wang
Journal:  Neurochem Res       Date:  2009-05-22       Impact factor: 3.996

Review 5.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration.

Authors:  Young-Don Kwak; Bin Wang; Jing Jing Li; Ruishan Wang; Qiyue Deng; Shiyong Diao; Yaomin Chen; Raymond Xu; Eliezer Masliah; Huaxi Xu; Jung-Joon Sung; Francesca-Fang Liao
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

7.  Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients.

Authors:  Susanne Petri; Klaus Krampfl; Kerstin Kuhlemann; Reinhard Dengler; Claudia Grothe
Journal:  Histochem Cell Biol       Date:  2008-12-19       Impact factor: 4.304

8.  Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats.

Authors:  Rina Eshet; Irit Gil-Ad; Olga Apelboym; Yael Segev; Moshe Phillip; Haim Werner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 9.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04

Review 10.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.